Annual General Meeting 2024

Tecan shareholders endorse all motions proposed by the Board of Directors

Annual General Meeting 2024: Tecan shareholders endorse all motions proposed by the Board of Directors

• Increase in the dividend from CHF 2.90 to CHF 3.00 per share
• Monica Manotas elected as additional independent member of the Board of Directors
• Lukas Braunschweiler, Myra Eskes, Oliver Fetzer, Matthias Gillner, Karen Huebscher, Christa Kreuzburg and Daniel R. Marshak re-elected as members of the Board of Directors
• Lukas Braunschweiler confirmed by shareholders as Chair of the Board
• Myra Eskes, Oliver Fetzer, Christa Kreuzburg and Daniel R. Marshak confirmed as members of the Compensation Committee
• Various amendments to the Articles of Incorporation approved
• All proposals relating to compensation approved
• Approval of the Report on Non-Financial Matters 2023 (Sustainability Report)

Männedorf, Switzerland, April 18, 2024 – The Annual General Meeting of the Tecan Group (SIX Swiss Exchange: TECN) endorsed all motions proposed by the Board of Directors. Shareholders approved the Annual Report, the financial statements and the consolidated financial statements, and granted discharge to the Board of Directors and the Management Board. They agreed to an increase in the dividend from CHF 2.90 to CHF 3.00 per registered share. Half of the dividend, i.e., CHF 1.50, will be paid out from the available capital contribution reserve and is therefore not subject to withholding tax. The payout will take place on April 24, 2024.

The shareholders elected Monica Manotas as an additional independent member of the Tecan Board of Directors. With her many years of international experience in the life science industry and her proven expertise in finance, the industrial engineer with Colombian and US citizenship will strengthen the Board in a variety of ways. All current members of the Board of Directors were confirmed by the shareholders for a term of one year: Dr. Lukas Braunschweiler, Myra Eskes, Dr. Oliver Fetzer, Matthias Gillner, Dr. Karen Huebscher, Dr. Christa Kreuzburg and Dr. Daniel R. Marshak. Lukas Braunschweiler was re-elected as Chair of the Board of Directors. The shareholders confirmed Myra Eskes, Oliver Fetzer, Christa Kreuzburg and Daniel R. Marshak as members of the Compensation Committee.